Radioactive tracer seeks out Hard-to-Treat cancers
NCT ID NCT07272642
Summary
This early study is testing a new radioactive imaging agent called LNTH-2403 in people with advanced cancers that have spread or can't be removed. The main goals are to see if it's safe and to track where it goes in the body using special scans. Researchers want to learn if this agent can reliably find and stick to certain types of tumors to help guide future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Icon Cancer Centre Hollywood
Nedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.